A consortium led by PAI Partners has increased its bid for Sanofi's consumer health business, Opella, by €200m, competing with Clayton Dubilier & Rice. Sanofi intends to keep a 50% stake and is looking for an investor for the other half. PAI promises to protect jobs in French production sites and invest €60m over five years. The potential sale has sparked concerns about job security and medicine shortages in France, leading to political backlash and strikes among Sanofi workers. Teljes cikk (Euronews.com)